# Group standardization of Chinese experts specification of operating techniques for facial embedded thread lift

**Authors:** Bing Shi

PMC · DOI: 10.3389/fsurg.2025.1750529 · 2026-01-16

## TL;DR

This paper introduces China's first standardized guidelines for facial thread lift procedures to improve safety and consistency in outcomes.

## Contribution

The paper presents the first expert consensus framework for facial thread lift techniques in China.

## Key findings

- The consensus framework improves thread lift safety and efficacy based on multicenter data.
- Region-specific protocols and anatomical stratification are key components of the new guidelines.
- The framework serves as a global benchmark for aesthetic training, especially for Asian facial anatomy.

## Abstract

Despite the global popularity of minimally invasive thread lifts, the absence of standardized protocols has led to significant variations in outcomes. This study establishes China's first expert consensus (T/CAPA 009-2023) on facial thread lift techniques, addressing critical gaps in operator training, material selection, and anatomical precision.

A multidisciplinary panel analyzed 2,143 PPDO thread procedures (2018–2022) across 35 institutions. The consensus framework integrates: 1) Graded facility/operator requirements (Grade III device management), 2) Anatomical stratification (SMAS, fat layers, ligament anchoring), and 3) Region-specific protocols (upper/mid/lower face, neck) with 14 illustrated surgical designs.

Multicenter data and anatomical studies demonstrate that this consensus framework improves thread lift safety and efficacy, though further RCTs are warranted to confirm long-term outcomes The hierarchical protocol serves as a global benchmark for aesthetic training programs, particularly in Asian facial anatomy.

## Full-text entities

- **Diseases:** heart disease (MESH:D006331), bruising (MESH:D003288), laxity (MESH:D007593), asymmetry (MESH:D005146), depressed (MESH:D003866), non-tuberculous (MESH:D014390), impaired glucose tolerance (MESH:D018149), of parotid gland (MESH:D010309), hypertension (MESH:D006973), facial diseases (MESH:D005155), Infection (MESH:D007239), immune disorders (MESH:D007154), confusion (MESH:D003221), AIDS (MESH:D000163), hemorrhage (MESH:D006470), mycobacterium infection (MESH:D009164), Damage (MESH:D020263), systemic diseases (MESH:D034721), duct (MESH:D001649), pain (MESH:D010146), neural injury (MESH:D014947), abscess (MESH:D000038), fibrosis (MESH:D005355), syphilis (MESH:D013587), Hematoma (MESH:D006406), swelling (MESH:D004487), hepatitis B, C (MESH:D006509), mental illness (MESH:D001523), lung diseases (MESH:D008171), diabetes (MESH:D003920), malignant tumors (MESH:D009369)
- **Chemicals:** PLGA (-), epinephrine (MESH:D004837)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12855474/full.md

---
Source: https://tomesphere.com/paper/PMC12855474